Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | SERPINH1 | P50454 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | FBP1 | P09467 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4126175 | 0.86 | ALDH1A1 (0.47) | ALDH1A1CYP2C19LMNAMEN1KMT2A | |
| SCHEMBL16683401 | 0.86 | ALDH1A1 (0.47) | ALDH1A1CYP2C19LMNAMEN1KMT2A | |
| SCHEMBL28732491 | 0.86 | ALDH1A1 (0.44) | ALDH1A1CYP2C19LMNASERPINH1MEN1 | |
| SCHEMBL16683404 | 0.84 | ALDH1A1 (0.46) | ALDH1A1CYP2C19LMNAMEN1POLB | |
| SCHEMBL16683403 | 0.84 | BRD4 (0.53) | ALDH1A1CYP2C19LMNAMEN1POLB | |
| SCHEMBL4120421 | 0.84 | BRD4 (0.53) | ALDH1A1CYP2C19LMNAMEN1POLB | |
| SCHEMBL4119806 | 0.84 | ALDH1A1 (0.46) | ALDH1A1CYP2C19LMNAMEN1POLB | |
| SCHEMBL2628014 | 0.84 | CPA1 (0.45) | ALDH1A1CYP2C19LMNAMEN1POLB | |
| SCHEMBL4111632 | 0.84 | CPA1 (0.45) | ALDH1A1CYP2C19LMNAMEN1POLB | |
| SCHEMBL4865124 | 0.84 | ALDH1A1 (0.66) | ALDH1A1CYP2C19LMNASERPINH1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9035075-B1 | Catalyst for organic reaction and method of use thereof | Research & Business Foundation Sungkyunkwan University (KR) | 2015-05-19 | — | — | US | disclosed |
| US-9035075-B1 | Catalyst for organic reaction and method of use thereof | Research & Business Foundation Sungkyunkwan University (KR) | 2015-05-19 | — | — | US | disclosed |
| US-20150119583-A1 | CATALYST FOR ORGANIC REACTION AND METHOD OF USE THEREOF | Research & Business Foundation Sungkyunkwan University (KR) | 2015-04-30 | — | — | US | disclosed |
| US-20150119583-A1 | CATALYST FOR ORGANIC REACTION AND METHOD OF USE THEREOF | Research & Business Foundation Sungkyunkwan University (KR) | 2015-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119583-A1 | CATALYST FOR ORGANIC REACTION AND METHOD OF USE THEREOF | SCO2, OGDH, AOC2 | ALDH1A1 2622/4885CYP2C19 269/4885LMNA 1954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.